Tramadol Hydrochloride
Product Images NDC 52959-688

4 FDA label images from H.j. Harkins Company Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Tramadol Hydrochloride (NDC 52959-688). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by H.j. Harkins Company Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

52959 688.jpg (52959 688)

52959 688.jpg (52959 688)
Label for Tramadol Hydrochloride 50 mg tablets, manufactured by Zydus, repackaged by H.J. Harkins Company Inc., Grover Beach, CA. The label includes multiple identical sections with the product name, NDC number 52959-0688-XX, expiration date 11/18/20, lot number TOL54ZY, and barcodes. Instructions state 'Take as directed by your Physician.' Caution about federal law and storage conditions is also present.*
FDA Label Image

Tramadol Graph (Tramadol Graph)

Tramadol Graph (Tramadol Graph)
A pharmacokinetic curve graph showing concentrations (ng/mL) of Tramadol and its metabolite M1 over time (hours). It compares multiple dose and single dose profiles for both Tramadol and M1, illustrating their concentration decline from 0 to 48 hours.*
FDA Label Image

Tramadol HCl (Tramadol HCl)

Tramadol HCl (Tramadol HCl)
Chemical structure of Tramadol Hydrochloride, showing molecular bonds and the arrangement of atoms including a methoxy group, a cyclohexane ring, and an amine group.*
FDA Label Image

Tramadol Clinical Graph (Tramadol Clinical Graph)

Tramadol Clinical Graph (Tramadol Clinical Graph)
A line chart titled 'Time to Discontinuation Due to Nausea/Vomiting' showing percent discontinuing on the y-axis and days in double-blind on the x-axis. The chart displays a red stepped line representing discontinuation over 25 days at a dose of 200 mg/day, illustrating an increasing trend in percent discontinuing due to nausea or vomiting.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.